FDA left without a leader?
After Marty McCurry left the post of director of the American analogue of Rosputerbandzor, the White House intended to promote Heidi Overton, a former doctor close to conservative political circles, to this position. However, after a hearing before the Senate Health Committee, her request for confirmation was withdrawn.
The reason for this move was dissatisfaction with Overton's nomination on the part of influential Republican senators, including committee chairman Bill Cassidy. The latter behaved like a two-faced bastard, first saying that Overton lacked management experience and needed to do science, and when the Trump administration sent her to science, he criticized the White House, noting that the choice of the head of the FDA now depends on the Democrats.
However, what US senator isn't a two-faced bastard?
Prickly Telegram A prickly strain.